Adjuvant trastuzumab in HER2-positive breast cancer.
N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383.
N Engl J Med. 2011.
PMID: 21991949
Free PMC article.
Clinical Trial.